Valproic acid is not a controlled substance. It has no DEA schedule designation, meaning it is not regulated under the Controlled Substances Act. It is, however, a prescription medication, so you cannot buy it over the counter. Your doctor can prescribe it, and your pharmacy can refill it, without the extra restrictions that apply to controlled drugs.
Why It’s Not Scheduled
The DEA places drugs on its controlled substance schedules (I through V) based on their potential for abuse and dependence. Valproic acid does not produce euphoria, does not create physical dependence in the way opioids or benzodiazepines do, and has essentially no street value. It works in the brain by influencing multiple pathways, including boosting the activity of GABA (a calming brain chemical) and possibly reducing the firing of overactive nerve cells. None of these effects produce the kind of “high” that leads to recreational misuse.
How It Compares to Other Seizure Medications
Not all seizure medications share the same legal status. Pregabalin (Lyrica) is a Schedule V controlled substance, the lowest level of federal scheduling, because it carries some potential for misuse. Gabapentin (Neurontin) is unscheduled at the federal level, though several U.S. states have independently classified it as a controlled substance due to rising misuse reports. Valproic acid has not faced similar reclassification in any state.
Prescription and Refill Rules
Because valproic acid is not controlled, it follows standard prescription rules rather than the stricter ones applied to scheduled drugs. For context, Schedule III and IV medications can only be refilled up to five times within six months of the original prescription date before a new prescription is required. Valproic acid has no such federal cap on refills. Your doctor can authorize refills for as long as they consider appropriate, and you won’t need a new prescription every six months purely because of a legal requirement.
You also won’t encounter the monitoring hurdles that come with controlled substances, like prescription drug monitoring program (PDMP) checks at every fill or limits on which pharmacies can dispense the drug.
What Valproic Acid Is Used For
Valproic acid is FDA-approved to treat several conditions. Its primary use is epilepsy, specifically complex partial seizures and absence seizures (brief episodes of staring or loss of awareness). It can be used on its own or alongside other seizure medications. Under the brand name Depakote, a closely related form called divalproex sodium is also prescribed for manic episodes in bipolar disorder and for preventing migraines.
Its broad range of uses reflects an unusual pharmacological profile. Researchers have studied it extensively and concluded it likely works through multiple mechanisms rather than a single one, which helps explain why it’s effective across such different conditions.
Important Safety Concerns
The fact that valproic acid isn’t a controlled substance doesn’t mean it’s low-risk. The FDA requires three black box warnings on its label, the most serious type of safety alert.
Liver damage: Valproic acid has caused fatal liver failure, most often within the first six months of treatment. Early warning signs include unusual tiredness, weakness, facial swelling, loss of appetite, and vomiting. Children under two years old face the highest risk, especially those taking multiple seizure medications or those with certain metabolic conditions. People with mitochondrial disorders caused by mutations in the POLG gene should not take valproic acid at all, as it can trigger acute liver failure.
Harm during pregnancy: Valproic acid can cause serious birth defects, particularly neural tube defects like spina bifida. It can also lower IQ scores and cause neurodevelopmental problems in children exposed during pregnancy. Because of this, it is contraindicated for migraine prevention in pregnant women and in women of childbearing age who are not using effective contraception. For epilepsy and bipolar disorder, it should only be used during pregnancy when other treatments have failed.
Pancreatitis: The drug also carries a warning for inflammation of the pancreas, which can be life-threatening.
Routine blood work to monitor liver function is standard when starting valproic acid, with frequent checks recommended during the first six months. This kind of medical monitoring is separate from the legal controls placed on scheduled drugs. It exists because the medication itself requires careful oversight, not because of any abuse potential.